This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Oxford NHS Researchers Recruit Global First Patient

Researchers at Oxford’s Churchill Hospital have recruited the first patient in the world to a trial into using gene therapy to attempt to cure haemophilia B.

Haemophilia B is a rare genetic disorder where the protein Factor IX, which helps the blood to clot, is missing. In the most severe cases, patients are at risk of frequent episodes of bleeding into their joints, resulting in arthritis at an early age. There is currently no cure.

For the full story on the Oxford University Hospitals website